Industry / Pharmaceutical Preparation Manufacturing
Trending Companies
Latest filings
6-K
MOR
Morphosys
24 Apr 24
Current report (foreign)
10:05am
6-K
RDHL
Redhill Biopharma
24 Apr 24
Current report (foreign)
7:05am
6-K
GSK
GSK
24 Apr 24
Us Fda Accepts New Indication Filing for Jemperli
6:45am
6-K
MOR
Morphosys
23 Apr 24
Current report (foreign)
10:14am
6-K
IMRN
Immuron Limited
23 Apr 24
Report of Foreign Private Issuer
6:06am
EFFECT
RDHL
Redhill Biopharma
23 Apr 24
Notice of effectiveness
12:15am
6-K
GMAB
Genmab
22 Apr 24
Current report (foreign)
4:14pm
144
SYBX
Synlogic
22 Apr 24
Notice of proposed sale of securities
4:12pm
8-K
TRVN
Trevena
22 Apr 24
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
PPCB
Propanc Biopharma
22 Apr 24
Entry into a Material Definitive Agreement
12:12pm
Upcoming Earnings Releases
AZN
Astrazeneca
$206,342.1 mm
25 Apr 24
MRK
Merck & Co
$301,270.0 mm
25 Apr 24
MOR
Morphosys
$1,379.7 mm
29 Apr 24
SVA
Sinovac Biotech
$643.8 mm
29 Apr 24
MED
Medifast
$580.4 mm
29 Apr 24
JAZZ
Jazz Pharmaceuticals
$7,336.7 mm
1 May 24
GSK
GSK
$81,560.8 mm
1 May 24
UTHR
United Therapeutics
$10,238.5 mm
1 May 24
TCRT
Alaunos Therapeutics
$28.3 mm
8 May 24
IGXT
IntelGenx Technologies
9 May 24
Stock splits Upcoming and recent stock splits
News
AstraZeneca Awarded $913M Contract By The Department Of Veteran Affairs For BTK Inhibitors
AZN
24 Apr 24
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?
IMMP
MRK
24 Apr 24
United Therapeutics Announces Xenothymokidney Transplant
UTHR
24 Apr 24
CureVac Has Started The Phase 1 Part Of A Combined Phase 1/2 Study Of An Investigational Influenza A (H5N1) Pre-Pandemic Vaccine Candidate Developed In Collaboration With GSK, H5N1 Is An Avian Influenza Virus
CVAC
GSK
24 Apr 24
Angle Inks New Commercial Agreement With AstraZeneca to Enhance DNA Damage Response Detection
AZN
24 Apr 24
AbbVie's Options Frenzy: What You Need to Know
ABBV
23 Apr 24
Exploring Analyst Estimates for Merck Q1 Earnings, Beyond Revenue and EPS
MRK
23 Apr 24
Understanding Merck & Co's Position In Pharmaceuticals Industry Compared To Competitors
MRK
23 Apr 24
As Part Of Wave Life Sciences' Ongoing Collaboration With GSK, GSK Has Selected Its First Two Oligonucleotide Programs, GSK Will Provide An Initiation Payment Of $12M
GSK
WVE
23 Apr 24
Looking Into Merck & Co's Recent Short Interest
MRK
23 Apr 24
Press releases
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
SUPN
24 Apr 24
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
JAZZ
24 Apr 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SUPN
24 Apr 24
United Therapeutics Announces World's First Successful Xenothymokidney Transplant
UTHR
24 Apr 24
Investment Opportunities in Biotech Amidst Federal Rate Uncertainties (ATNM)
ABBV
ATNM
AZN
22 Apr 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
SUPN
20 Apr 24
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b 'ASCEND-NASH' Trial
HEPA
19 Apr 24
Health Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with fluoropyrimidine- and platinum-containing chemotherapy
MRK
19 Apr 24
Actinium Pharmaceuticals (ATNM) Leads Biotech Innovation Amid Economic Uncertainty
ABBV
ATNM
AZN
19 Apr 24
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
ABBV
18 Apr 24
Transcripts
IGXT
Earnings call transcript
2023 Q4
21 Mar 24
EBS
Earnings call transcript
2023 Q4
6 Mar 24
JAZZ
Earnings call transcript
2023 Q4
28 Feb 24
SUPN
Earnings call transcript
2023 Q4
27 Feb 24
UTHR
Earnings call transcript
2023 Q4
21 Feb 24
MED
Earnings call transcript
2023 Q4
20 Feb 24
AXSM
Earnings call transcript
2023 Q4
20 Feb 24
ABBV
Earnings call transcript
2023 Q4
2 Feb 24
MRK
Earnings call transcript
2023 Q4
1 Feb 24
TRVN
Earnings call transcript
2023 Q3
14 Nov 23
Patents
Utility
Modified Imidazopyridines As Glucosylceramide Synthase Inhibitors
MRK
18 Jan 24
Utility
Antibodies Targeting C5AR
MOR
18 Jan 24
Utility
Modulators of the Integrated Stress Pathway
ABBV
18 Jan 24
Utility
GHB Formulation and Method for Its Manufacture
JAZZ
18 Jan 24
Utility
Polycyclic Cap-dependent Endonuclease Inhibitors for Treating or Preventing Influenza
MRK
18 Jan 24
Utility
Methods of administering solriamfetol to lactating women
AXSM
16 Jan 24
Utility
Well plate assembly with pressure release mechanism
MRK
16 Jan 24
Utility
Methods of administering solriamfetol to lactating women
AXSM
16 Jan 24
Utility
Combination of an ANTI-CD19 Antibody and a Bruton's Tyrosine Kinase Inhibitor and Uses Thereof
MOR
11 Jan 24
Utility
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
ABBV
11 Jan 24
Reddit threads
Reality income - Just cannot dip my toes.
AA
ADC
WPC
24 Apr 24
Best Dividend stock right now?
G
ET
ARCC
20 Apr 24
All in on one or spread the love?
IBM
CVX
ABBV
20 Apr 24
How many different funds do you have in your dividend portfolio?
PDI
MSD
ARCC
19 Apr 24
Are you using this dip in the market as a buying opportunity or expecting it to tank more?
IBIT
SBUX
STT
18 Apr 24
Long-term investor checking in. Should I sell some LLY and buy some PFE?
LLY
PFE
NVO
17 Apr 24
$100K at 25, and it’s still probably not enough
QQQ
KO
ABBV
17 Apr 24
Mentality exchange
SBUX
MRK
16 Apr 24
What should I complete next?
SBUX
AAPL
KO
14 Apr 24
Late Stage Beginner
PG
ABBV
CVX
12 Apr 24